Business
AstraZeneca US COVID-19 vaccine trial may resume as soon as this week – Sydney Morning Herald
The pharma giant’s coronavirus vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed…
In a research and development briefing held for CSL investors on Tuesday, the company’s chief scientific officer Dr Andrew Nash said preparations to produce both vaccines were moving along well and production of the AstraZeneca product could start early next year.
He said the AstraZeneca/Oxford and University of Queensland projects used different approaches, with UQ’s being a more “classical” vaccine model while AstraZeneca’s was a newer approach, and it was a positive that both projects could be…
-
Noosa News9 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business14 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business12 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025